Focused On Life

Developing novel therapies for serious diseases

Learn More

Driven By Science

Rapid, efficient, cost-effective approach

Learn More

Focused On Life

Developing novel therapies for serious diseases

Driven By Science

Rapid, efficient, cost-effective approach

Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.

Medivation is proud to be a 2016 Top Workplace

Learn More

Latest News

August 22, 2016
Pfizer To Acquire Medivation Learn More